Invacare is a manufacturer of medical equipment used in non-acute care settings. Although the net sales decreased 2.3% to $244.6 million in the fourth quarter of 2018, it was above the consensus analysts' estimate of $240.53 million. Outlook Therapeutics is a clinical-stage biopharmaceutical company developing a drug for the treatment of wet age-re
Analyst Ratings For AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) Today, Credit Suisse Group initiated coverage on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) with a Outperform. There are 7 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock. The current consensus rating on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) is Buy with a
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced that it has submitted a continuation patent application with U.S. Patent and Trademark Office to broaden the claims relating to the use of AD04 for opioid dependence and abuse, commonly referred to as Opio
Days after the FDA blessed Mercks effort to challenge Pfizers mega-blockbuster Prevnar 13 with a breakthrough designation, Affinivax is making the leap into the clinic with its own take on the pneumococcal vaccine. Weve done in less than five years at Affinivax what the big vaccine players like Merck and Pfizer and Sanofi and GSK have been trying t
Agency: " Food and Drug Administration, HHS." Under the Paperwork Reduction Act of 1995, Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the no
Analyst Ratings For Agios Pharmaceuticals Inc (NASDAQ:AGIO) Today, Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock received an upgrade by Leerink Swann from Market Perform to Outperform. There are 9 Buy Ratings, 2 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock. The current consensus rating on Agios Pharmaceuticals Inc (NASDAQ:AGIO)
The following should be read in conjunction with our consolidated financial statements and related notes beginning on page F 1 of this Annual Report. We earn revenue on net sales of VIVITROL, ARISTADA and ARISTADA INITIO, which are proprietary products that we manufacture, market and sell in the U.S., and manufacturing and/or royalty revenues on
An Indian national who heads a pharmaceutical company in Russia has been reportedly hospitalized after falling victim to an armed attack in Moscow. Four unknown assailants beat Jyoti Loomba and his driver with bats on the southeastern outskirts of Moscow Thursday evening, a police source told the RBC news website. They then shot Loomba several time
About two years ago, Astellas licensed a novel pneumococcal vaccine technology from Affinivax with eyes on Pfizers Prevnar 13. The first patient has been dosed with the investigational vaccine, dubbed ASP3772, in a phase 1/ 2 study that aims to evaluate the vaccines safety, tolerability and immunogenicity, Affinivax said on Wednesday. We believe th
CStone Pharmaceuticals today announced that the National Medical Products Administration recently approved a Phase III clinical trial in China for its partnered drug candidate avapritinib as a third-line treatment against KIT-driven gastrointestinal stromal tumors. According to data from the NAVIGATOR Phase I clinical trial reported as of October
The US Food and Drug Administration has accepted for priority review a supplemental Biologics License Application for Mercks Bavencio in combination with Inlyta for patients with advanced renal cell carcinoma. "Our alliance is focused on the development of potential new treatment options for patients with cancers that have high unmet medical needs
Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad s Droplet Digital PCR technology, and the QXDx BCR-ABL% IS Kit are the industry s first digital PCR products to receive U.S. Food and Drug Administration clearance. Used t
Bioblast Pharma Ltd., a clinical-stage, orphan disease-focused biotechnology company, and Team Sanfilippo, a nonprofit medical research foundation founded by parents of children with Sanfilippo Syndrome today announced a clinical collaboration to evaluate the safety and efficacy of Bioblast s proprietary Trehalose solution for the treatment of
BioCorRx Inc., based in Anaheim, CA, Leader in addiction treatment solutions and drug development implementation, today announced that Brady Granier, CEO/President and Lourdes Felix, CFO/COO, will present live at VirtualInvestorConferences.com on February 20 th. DATE: Wednesday, February 20 th TIME: 1:00PM EST LINK: https://tinyurl.com/0220prepr.
DATES: The meeting will be held on March 20, 2019, from 8:30 a.m. to 4:45 p.m., and March 21, 2019, from 8:30 a.m. to 5 p.m.. ADDRESSES: FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room, Silver Spring, MD 20993-0002. Answers to commonly asked questions including information regarding special accommodations
Global IoT Enabled Healthcare Equipment Market Forecast, Market Size, 2018-2023,$ Billion. LONDON, GREATER LONDON, UK, February 15, 2019/ EINPresswire.com/ Wearable medical devices and diagnostic companies are increasingly integrating Bluetooth wireless technology with medical devices, a new report from The Business Research Company, IoT Enabled.
Cerecor Inc., a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments in rare and orphan diseases in pediatrics and neurology, announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,202,363 on Feb. 12, 2019, which is directed to CERC 301, an oral, NR2B-specific, NMDA re
The Clinical Trial Supplies studies spreads fantastic statistics that makes the document a handy asset for managers, industry professionals and different key individuals alongside charts and tables to help recognize Clinical Trial Supplies market patterns, drivers and challenges. The development rate is based on the instructional exam of the facts
Harrisburg, NC 02/15/2019 Global Contract Research Organization Market Size, Status And Forecast 2025. This report studies the Global Contract Research Organization market size, industry status and forecast, competition landscape and growth opportunity. Food Service Market Segment by Region: North America, United States, Canada, Mexico, Asia-
COVENTRY, R.I.- Rhodes Pharmaceuticals is a sinister drugmaker that most Rhode Islanders have never heard of, contends Domenic Esposito. In September, The Financial Times first reported the link between Rhodes Pharmaceuticals and Purdue Pharma, manufacturer of the controversial painkiller OxyContin. In 2007, four months after executives of Purdue p
CymaBay Therapeutics, Inc., today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for seladelpar for the treatment of early stage primary biliary cholangitis in combination with ursodeoxycholic acid in adult patients with an inadequate response to UDCA, or as monotherapy in adults unable to tolera
Decipher Biosciences, a leader in the field of urologic cancer genomics, today announced a research collaboration with Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, to apply genomic tumor profiling using the Decipher assay and GRID software to identify prostate cancer
The "Degenerative Disc Disease- Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com' s offering. Degenerative Disc Disease- Pipeline Insight, 2019 offers comprehensive insights of the pipeline therapeutics scenario and growth prospects across Degenerative Disc Disease development. The report provides detailed coverage of
Denali Therapeutics Inc., a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases, today announced initiation of dosing in a Phase 1 b clinical study of DNL747 in patients with Alzheimer s disease, in collaboration with its partner Sanofi.. We are excited to advance DNL747 in a secon
The European Commission has expanded the marketing authorisation of Takeda Pharmaceuticals Adcetris to adults with previously untreated CD30+ Stage IV Hodgkin lymphoma. It is based on Seattle Genetics technology. Takeda Pharmaceutical vice-president and Oncology Clinical Research and Development head Jess Gmez-Navarro said: We are pleased that the.
